Format

Send to

Choose Destination
Clin Pediatr (Phila). 2019 Jan 7:9922818822980. doi: 10.1177/0009922818822980. [Epub ahead of print]

Asthma Medication Prescribing Practices in Pediatric Office Visits.

Author information

1
1 Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, TX, USA.
2
2 Novartis Pharmaceuticals Corp, East Hanover, NJ, USA.
3
3 NorthShore University HealthSystem, Evanston, IL, USA.
4
4 University of California, San Francisco, CA, USA.
5
5 Boys Town National Research Hospital, Boys Town, NE, USA.

Abstract

This cross-sectional study examined how asthma control, demographic, and clinical characteristics are associated with the use of asthma medications in pediatric office visits in the United States. Data from the 2012-2015 National Ambulatory Medical Care Survey included patients aged 6 to 17 years, with asthma as a primary diagnosis (International Classification of Diseases, Ninth Revision, Clinical Modification, code 493.xx). Descriptive weighted analysis evaluated asthma medication use. Multivariable logistic regression examined characteristics associated with asthma prescribing practices. An estimated 2.5 million pediatric office visits were made annually for asthma. The majority of asthma visits involved males (59.3%), children aged 6 to 11 years (54.8%), and whites (73.6%). Several clinical and demographic characteristics contributed to the variations in overall asthma medication use as well as specific drug classes. Lack of documentation of asthma control and uncontrolled asthma were associated with oral corticosteroid and inhaled corticosteroid use in pediatric asthma patients, but not with overall asthma medication use.

KEYWORDS:

asthma; inhaled corticosteroids; medication prescribing; oral corticosteroids; pediatric

PMID:
30614250
DOI:
10.1177/0009922818822980

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center